DMPX
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.162.258 |
Chemical and physical data | |
Formula | C10H10N4O2 |
Molar mass | 218.216 g·mol−1 |
3D model (JSmol) | |
| |
|
DMPX (3,7-dimethyl-1-propargylxanthine) is a caffeine analog which displays affinity for A2 adenosine receptors, in contrast to the A1 subtype receptors.[1] DMPX had 28 times and 15 times higher potency than caffeine in blocking, respectively, the peripheral and central effects of the adenosine agonist NECA. The locomotor stimulation caused by DMPX (ED50 10 μmol/kg) was similarly higher than caffeine.[1]
See also
- DPCPX
- 8-PT
- CPX (8-CPT)
- 8-Chlorotheophylline
- Theophylline
References
Receptor (ligands) |
| ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Transporter (blockers) |
| ||||||||||
Enzyme (inhibitors) |
| ||||||||||
Others | |||||||||||
See also: Receptor/signaling modulators |
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.